We are live on ! Find out more
PEARW

Pear Therapeutics, Inc. Warrant
PEARW

Delisted

PEARW was delisted on the 18th of April, 2023.

Back to rankings

Fund managers haven’t disclosed any holdings of PEARW yet.

PEARW Hedge Fund Activity: Q3 2023 in Review

0 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Pear Therapeutics, Inc. Warrant (PEARW) for Q3 2023, worth a combined $0 — down 100% from $277 a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of PEARW and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Advisory Research, exiting entirely with an estimated $208 sold.

  • 0 institutional investors held Pear Therapeutics, Inc. Warrant (PEARW) as of Q3 2023, down from 2 in Q2 2023.
  • Funds reported $0 of Pear Therapeutics, Inc. Warrant stock for Q3 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Pear Therapeutics, Inc. Warrant positions in Q3 2023 and 2 closed out, a net change of -2 holders.
  • The largest Pear Therapeutics, Inc. Warrant seller in Q3 2023 was Advisory Research, an estimated $208 sold.

Based on aggregated 13F filings for Q3 2023.